Lorusso, Domenica
Lorusso, Domenica
Dipartimento Scienze Biomediche
"Tumori della vulva e della vagina"
2013-01-01 Lorusso, D
3D vision improves outcomes in early cervical cancer treated with laparoscopic type B radical hysterectomy and pelvic lymphadenectomy
2017-01-01 Raspagliesi, F; Bogani, G; Martinelli, F; Signorelli, M; Scaffa, C; Sabatucci, I; Lorusso, D; Ditto, A
[Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.]
2021-01-01 Danesi, R.; Cremolini, C.; Ciccarone, F.; Lorusso, D.
A critical assessment on the role of sentinel node mapping in endometrial cancer
2015-01-01 Bogani, G; Ditto, A; Martinelli, F; Signorelli, M; Perotto, S; Lorusso, D; Raspagliesi, F
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: A pilot study
2006-01-01 Fagotti, Anna; Ferrandina, Gabriella; Fanfani, Francesco; Ercoli, Alfredo; Lorusso, D; Rossi, Marco; Scambia, Giovanni
A multicentre phase 2 study of carboplatin (C) plus pegylated liposomal doxorubicin (PLO) as first-line chemotherapy for patients (pts) with advanced or recurrent endometrial carcinoma (AEC): The END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer) Group
2006-01-01 Lorusso, D; Pignata, S.; Scambia, G.; Zagonel, V.; Riva, N.; Febbraro, A.; Pisano, C.; Greggi, S.; Breda, E.; Morabito, A.
A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group
2007-01-01 Pignata, S.; Scambia, G.; Pisano, C.; Breda, E.; Di Maio, M.; Greggi, S.; Ferrandina, G.; Lorusso, D; Zagonel, V.; Febbraro, A.; Riva, N.; De Rosa, V.; Gallo, C.; Perrone, F.
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy
2011-01-01 Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.; Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study
2008-01-01 Pignata, Sandro; Breda, Enrico; Scambia, Giovanni; Pisano, Carmela; Zagonel, Vittorina; Lorusso, D; Greggi, Stefano; De Vivo, Rocco; Ferrandina, Gabriella; Gallo, Ciro; Perrone, Francesco
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
2019-01-01 Harter, P; Sehouli, J; Lorusso, D; Reuss, A; Vergote, I; Marth, C; Kim, Jw; Raspagliesi, F; Lampe, B; Aletti, G; Meier, W; Cibula, D; Mustea, A; Mahner, S; Runnebaum, Ib; Schmalfeldt, B; Burges, A; Kimmig, R; Scambia, G; Greggi, S; Hilpert, F; Hasenburg, A; Hillemanns, P; Giorda, G; von Leffern, I; Schade-Brittinger, C; Wagner, U; du Bois, A.
A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
2018-01-01 Bogani, G; Tagliabue, E; Signorelli, M; Ditto, A; Martinelli, F; Chiappa, V; Mosca, L; Sabatucci, I; Leone Roberti Maggiore, U; Lorusso, D; Raspagliesi, F.
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
2014-01-01 Lorusso, D; Petrelli, F; Coinu, A; Raspagliesi, F; Barni, S
A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy
2008-01-01 Fagotti, A.; Fanfani, F.; Rossitto, C.; Lorusso, D; De Gaetano, A. M.; Giordano, A.; Vizzielli, G.; Scambia, G.
Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies
2017-01-01 Martinelli, Fabio; Ditto, Antonino; Bogani, Giorgio; Signorelli, Mauro; Chiappa, Valentina; Lorusso, Domenica; Haeusler, Edward; Raspagliesi, Francesco
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment
2021-01-01 Nero, C; Ciccarone, F; Pietragalla, A; Duranti, S; Daniele, G; Scambia, G; Lorusso, D
Adoptive immunotherapy with cytokine-induced killer cells generated with a new GMP-grade protocol
2012-01-01 Rutella, S.; Bonanno, G.; Iudicone, P.; Fioravanti, D.; Procoli, A.; Lavorino, C.; Foddai, M. L.; Lorusso, D; Bertaina, A.; Vacca, M.; Ipsevich, F.; Nuti, M.; Scambia, G.; Pierelli, L.
Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol
2012-01-01 Rutella, Sergio; Iudicone, Paola; Bonanno, Giuseppina; Fioravanti, Daniela; Procoli, Annabella; Lavorino, Claudio; Foddai Maria, Laura; Lorusso, D; Martinelli, Enrica; Vacca, Michele; Ipsevich, Francesco; Nuti, Marianna; Scambia, Giovanni; Pierelli, Luca
Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor
2013-01-01 Raspagliesi, F; Ditto, A; Martinelli, F; Haeusler, E; Lorusso, D
Advanced vulvar carcinoma: Is it worth operating? A perioperative management protocol for radical and reconstructive surgery
2006-01-01 Fanfani, Francesco; Garganese, Giorgia; Fagotti, Anna; Lorusso, D; Gagliardi Maria, Lucia; Rossi, Marco; Salgarello, Marzia; Scambia, Giovanni
Advances in laparoscopic surgery for cervical cancer
2019-01-01 Bogani, G; Maggiore, Ulr; Rossetti, D; Ditto, A; Martinelli, F; Chiappa, V; Ferla, S; Indini, A; Sabatucci, I; Lorusso, D; Raspagliesi, F
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| "Tumori della vulva e della vagina" | 1-gen-2013 | Lorusso, D | |
| 3D vision improves outcomes in early cervical cancer treated with laparoscopic type B radical hysterectomy and pelvic lymphadenectomy | 1-gen-2017 | Raspagliesi, F; Bogani, G; Martinelli, F; Signorelli, M; Scaffa, C; Sabatucci, I; Lorusso, D; Ditto, A | |
| [Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.] | 1-gen-2021 | Danesi, R.; Cremolini, C.; Ciccarone, F.; Lorusso, D. | |
| A critical assessment on the role of sentinel node mapping in endometrial cancer | 1-gen-2015 | Bogani, G; Ditto, A; Martinelli, F; Signorelli, M; Perotto, S; Lorusso, D; Raspagliesi, F | |
| A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: A pilot study | 1-gen-2006 | Fagotti, Anna; Ferrandina, Gabriella; Fanfani, Francesco; Ercoli, Alfredo; Lorusso, D; Rossi, Marco; Scambia, Giovanni | |
| A multicentre phase 2 study of carboplatin (C) plus pegylated liposomal doxorubicin (PLO) as first-line chemotherapy for patients (pts) with advanced or recurrent endometrial carcinoma (AEC): The END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer) Group | 1-gen-2006 | Lorusso, D; Pignata, S.; Scambia, G.; Zagonel, V.; Riva, N.; Febbraro, A.; Pisano, C.; Greggi, S.; Breda, E.; Morabito, A. | |
| A multicentre phase II study of carboplatin plus pegylated liposomal doxorubicin as first-line chemotherapy for patients with advanced or recurrent endometrial carcinoma: the END-1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) group | 1-gen-2007 | Pignata, S.; Scambia, G.; Pisano, C.; Breda, E.; Di Maio, M.; Greggi, S.; Ferrandina, G.; Lorusso, D; Zagonel, V.; Febbraro, A.; Riva, N.; De Rosa, V.; Gallo, C.; Perrone, F. | |
| A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy | 1-gen-2011 | Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I.; Pignata, S.; Amant, F.; Scambia, G.; Sorio, R.; Breda, E.; Rasch, W.; Hernes, K.; Pisano, C.; Leunen, K.; Lorusso, D; Cannella, L.; Vergote, I. | |
| A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study | 1-gen-2008 | Pignata, Sandro; Breda, Enrico; Scambia, Giovanni; Pisano, Carmela; Zagonel, Vittorina; Lorusso, D; Greggi, Stefano; De Vivo, Rocco; Ferrandina, Gabriella; Gallo, Ciro; Perrone, Francesco | |
| A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms | 1-gen-2019 | Harter, P; Sehouli, J; Lorusso, D; Reuss, A; Vergote, I; Marth, C; Kim, Jw; Raspagliesi, F; Lampe, B; Aletti, G; Meier, W; Cibula, D; Mustea, A; Mahner, S; Runnebaum, Ib; Schmalfeldt, B; Burges, A; Kimmig, R; Scambia, G; Greggi, S; Hilpert, F; Hasenburg, A; Hillemanns, P; Giorda, G; von Leffern, I; Schade-Brittinger, C; Wagner, U; du Bois, A. | |
| A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses | 1-gen-2018 | Bogani, G; Tagliabue, E; Signorelli, M; Ditto, A; Martinelli, F; Chiappa, V; Mosca, L; Sabatucci, I; Leone Roberti Maggiore, U; Lorusso, D; Raspagliesi, F. | |
| A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer | 1-gen-2014 | Lorusso, D; Petrelli, F; Coinu, A; Raspagliesi, F; Barni, S | |
| A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy | 1-gen-2008 | Fagotti, A.; Fanfani, F.; Rossitto, C.; Lorusso, D; De Gaetano, A. M.; Giordano, A.; Vizzielli, G.; Scambia, G. | |
| Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies | 1-gen-2017 | Martinelli, Fabio; Ditto, Antonino; Bogani, Giorgio; Signorelli, Mauro; Chiappa, Valentina; Lorusso, Domenica; Haeusler, Edward; Raspagliesi, Francesco | |
| Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment | 1-gen-2021 | Nero, C; Ciccarone, F; Pietragalla, A; Duranti, S; Daniele, G; Scambia, G; Lorusso, D | |
| Adoptive immunotherapy with cytokine-induced killer cells generated with a new GMP-grade protocol | 1-gen-2012 | Rutella, S.; Bonanno, G.; Iudicone, P.; Fioravanti, D.; Procoli, A.; Lavorino, C.; Foddai, M. L.; Lorusso, D; Bertaina, A.; Vacca, M.; Ipsevich, F.; Nuti, M.; Scambia, G.; Pierelli, L. | |
| Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol | 1-gen-2012 | Rutella, Sergio; Iudicone, Paola; Bonanno, Giuseppina; Fioravanti, Daniela; Procoli, Annabella; Lavorino, Claudio; Foddai Maria, Laura; Lorusso, D; Martinelli, Enrica; Vacca, Michele; Ipsevich, Francesco; Nuti, Marianna; Scambia, Giovanni; Pierelli, Luca | |
| Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor | 1-gen-2013 | Raspagliesi, F; Ditto, A; Martinelli, F; Haeusler, E; Lorusso, D | |
| Advanced vulvar carcinoma: Is it worth operating? A perioperative management protocol for radical and reconstructive surgery | 1-gen-2006 | Fanfani, Francesco; Garganese, Giorgia; Fagotti, Anna; Lorusso, D; Gagliardi Maria, Lucia; Rossi, Marco; Salgarello, Marzia; Scambia, Giovanni | |
| Advances in laparoscopic surgery for cervical cancer | 1-gen-2019 | Bogani, G; Maggiore, Ulr; Rossetti, D; Ditto, A; Martinelli, F; Chiappa, V; Ferla, S; Indini, A; Sabatucci, I; Lorusso, D; Raspagliesi, F |